C12N 5/525
Freeze protecting agents
Official title: {Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators}
C12N5/525 (Freeze protecting agents) appears on 4 US grants and 54 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 54
- Assignees
- 52
- Inventors
- 195
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 2 |
| 2025 | 2 | 19 |
| 2026 | 2 | 29 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for in vitro expansion of cryopreserved cord blood-derived regulatory t cells (Tregs) with high recovery rate30 Jun 2026US 12,668,779 B2Central South University
- Composition for cryoprotection including DNA nanostructure, and method for using same20 Jan 2026US 12,527,319 B2Korea University Research and Business Foundation
- Use of polyelectrolytes as cryoprotectants and a method of cryopreservation with their use16 Dec 2025US 12,495,790 B2Uniwersytet Jagiellonski
- Agent for promoting undifferentiation and cryoprotective agent using aprotic zwitterion2 Dec 2025US 12,484,574 B2National University Corporation Kanazawa University
- Methods of cell preservation20 Aug 2026US 2026/0242746 A1Be Biopharma, Inc.
- Cryoprotection of cells20 Aug 2026US 2026/0242747 A1Celaid Therapeutics Inc.
- Formulation for cell cryopreservation20 Aug 2026US 2026/0242748 A1Encell Co., Ltd.
- Tumor storage and cell culture compositions13 Aug 2026US 2026/0234568 A1Iovance Biotherapeutics, Inc.
- Frozen activated platelet compositions and collections, and methods of making and using the same13 Aug 2026US 2026/0234569 A1Cellphire, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.